Trastuzumab plus adjuvant chemotherapy for HER2-positive breast cancer: Final planned joint analysis of overall survival (OS) from NSABP B-31 and NCCTG N9831 Meeting Abstract
| Authors: | Romond, E.; Suman, V. J.; Jeong, J. H.; Sledge, G. W. Jr; Geyer, C. E. Jr; Martino, S.; Rastogi, P.; Gralow, J.; Swain, S. M.; Winer, E.; Colon-Otero, G.; Hudis, C.; Paik, S.; Davidson, N.; Mamounas, E. P.; Zujewski, J. A.; Wolmark, N.; Perez, E. A.; National Surgical Adjuvant Breast and Bowel Project (NSABP) Operations and Biostatistical Centers |
| Abstract Title: | Trastuzumab plus adjuvant chemotherapy for HER2-positive breast cancer: Final planned joint analysis of overall survival (OS) from NSABP B-31 and NCCTG N9831 |
| Meeting Title: | 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 72 |
| Issue: | 24 Suppl. |
| Meeting Dates: | 2012 Dec 4-8 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2012-12-15 |
| Language: | English |
| ACCESSION: | WOS:000209704900026 |
| DOI: | 10.1158/0008-5472.sabcs12-s5-5 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: S5-5 -- Source: Wos |
